A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 5, 2007, Pages 694-703

  Bleeker Rovers, Chantal P ^a   Vos, Fidel J ^a   Mudde, Aart H ^b   Dofferhoff, Anton S M ^c   De Geus Oei, Lioe Fee ^a   Rijnders, Anton J ^d   Krabbe, Paul F M ^a   Corstens, Frans H M ^a   Van Der Meer, Jos W M ^a   Oyen, Wim J G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SLINGELAND HOSPITAL   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

18F fluorodeoxyglucose; Diagnosis; Fever of unknown origin; Infection; Inflammation; PET

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSITRON EMISSION TOMOGRAPHY; PYREXIA IDIOPATHICA; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; DECISION SUPPORT TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER OF UNKNOWN ORIGIN; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS;

EID: 34247593050     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0295-z     Document Type: Article

References (27)

1. Barbado FJ, Vazquez JJ, Pena JM, Arnalich F, Ortiz-Vazquez J. Pyrexia of unknown origin: changing spectrum of diseases in two consecutive series. Postgrad Med J 1992;68:884-7.
2. Kazanjian PH. Fever of unknown origin: review of 86 patients treated in community hospitals. Clin Infect Dis 1992;15:968-73.
3. Knockaert DC, Vanneste LJ, Vanneste SB, Bobbaers HJ. Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch Intern Med 1992;152:51-5.
4. de Kleijn EM, van der Meer JW. Fever of unknown origin (FUO): report on 53 patients in a Dutch university hospital. Neth J Med 1995;47:54-60.
5. de Kleijn EM, Vandenbroucke JP, van der Meer JW. Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore) 1997;76:392-400.
6. Tabak F, Mert A, Celik AD, Ozaras R, Altiparmak MR, Ozturk R, et al. Fever of unknown origin in Turkey. Infection 2003;31:417-20.
7. Vanderschueren S, Knockaert D, Adriaenssens T, Demey W, Dumez A, Blockmans D, et al. From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med 2003;163:1033-41.
8. Saltoglu N, Tasova Y, Midikli D, Aksu HS, Sanli A, Dundar IH. Fever of unknown origin in Turkey: evaluation of 87 cases during a nine-year-period of study. J Infect 2004;48:81-5.
9. Ergonul O, Willke A, Azap A, Tekeli E. Revised definition of 'fever of unknown origin': limitations and opportunities. J Infect 2005;50:1-5.
10. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000;30:150-85.
11. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-80.
12. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med 1995;36:1854-61.
13. 18F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001;32:191-6.
14. Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, et al. Fever of unknown origin: prospective comparison of [18F] FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med 2000;27:1617-25.
15. Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun 2001;22:779-83.
16. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004;31:29-37.
17. 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging 2004;31:622-6.
18. Buysschaert I, Vanderschueren S, Blockmans D, Mortelmans L, Knockaert D. Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med 2004;15:151-6.
19. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
20. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
21. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 1990;33:1114-21.
22. Fautrel B, Zing E, Golmard JL, Le Moel G, Bissery A, Rioux C, Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) 2002;81:194-200.
23. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78.
24. 111In-granulocyte scintigraphy in patients with fever of unknown origin. J Nucl Med 2002;43:140-4.
25. de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on nonpathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging 2005;32:98-101.
26. Bleeker-Rovers CP, Boerman OC, Rennen HJ, Corstens FH, Oyen WJ. Radiolabeled compounds in diagnosis of infectious and inflammatory disease. Curr Pharm Des 2004;10:2935-50.
27. Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000;108:246-9.